New Refuse-to-File Mechanism for Pharmaceutical Registrations in Hong Kong Effective July 1, 2024

The Pharmacy and Poisons (Registration of Pharmaceutical Products and Substances: Certification of Clinical Trial/Medicinal Test) Committee has announced the implementation …

read more...

Singapore HSA Updates Labelling Guideline for Therapeutic Products

On 28th March 2024, HSA revises “Appendix 7: Points to Consider for Singapore Labelling of the Guidance on Therapeutic Product …

read more...

More News